Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Diseases of the Thyroid

  Free Subscription

Articles published in Anticancer Res

Retrieve available abstracts of 38 articles:
HTML format

Single Articles

    November 2020
  1. KIM SH, Cho YK, Huh JH, Kang JG, et al
    Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells.
    Anticancer Res. 2020;40:6137-6150.
    PubMed     Abstract available

  2. NISMAN B, Allweis TM, Carmon E, Kadouri L, et al
    Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer.
    Anticancer Res. 2020;40:6417-6428.
    PubMed     Abstract available

    July 2020
  3. CHO JM, Lee HJ, Chung JH, Kim WY, et al
    Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness.
    Anticancer Res. 2020;40:3801-3809.
    PubMed     Abstract available

    June 2020
  4. SAMHOURI L, Kriz J, Elsayad K, Channaoui M, et al
    The Role of Radiotherapy for Patients With Thyroid Cancer in the Modern Era.
    Anticancer Res. 2020;40:3379-3386.
    PubMed     Abstract available

    March 2020
  5. KIM HJ, Lee HJ, Jung JH, Kim WW, et al
    Ultrasound Assessment of Synchronous Thyroid Nodules in Patients With Papillary Thyroid Cancer: A Nodule-by-nodule Analysis Between Ultrasound and Pathology.
    Anticancer Res. 2020;40:1779-1786.
    PubMed     Abstract available

    February 2020
  6. SUZUKI H, Nishikawa D, Beppu S, Terada H, et al
    Prognostic Value of Age and Distant Metastasis in Differentiated Thyroid Carcinoma Undergoing Salvage Surgery.
    Anticancer Res. 2020;40:1127-1133.
    PubMed     Abstract available

    August 2019
  7. HUANG TS, Lee JJ, Li YS, Cheng SP, et al
    Ethacridine Induces Apoptosis and Differentiation in Thyroid Cancer Cells In Vitro.
    Anticancer Res. 2019;39:4095-4100.
    PubMed     Abstract available

  8. DOI K, Tsunoda T, Koyanagi M, Tanaka Y, et al
    Zfat Is Indispensable for the Development of Erythroid Cells in the Fetal Liver.
    Anticancer Res. 2019;39:4495-4502.
    PubMed     Abstract available

    July 2019
  9. STAUB Y, Nishiyama A, Suga Y, Fujita M, et al
    Clinical Characteristics Associated With Lenvatinib-induced Fistula and Tumor-related Bleeding in Patients With Thyroid Cancer.
    Anticancer Res. 2019;39:3871-3878.
    PubMed     Abstract available

    June 2019
  10. KARAGIANNIS AK, Philippou A, Tseleni-Balafouta S, Zevolis E, et al
    IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer.
    Anticancer Res. 2019;39:2811-2819.
    PubMed     Abstract available

  11. MIRONSKA A, Lukaszewicz-Zajac M, Mroczko B
    Clinical Significance of Selected Chemokines in Thyroid Cancer.
    Anticancer Res. 2019;39:2715-2720.
    PubMed     Abstract available

    May 2019
  12. SAEJIA P, Lirdprapamongkol K, Svasti J, Paricharttanakul NM, et al
    Perfluorooctanoic Acid Enhances Invasion of Follicular Thyroid Carcinoma Cells Through NF-kappaB and Matrix Metalloproteinase-2 Activation.
    Anticancer Res. 2019;39:2429-2435.
    PubMed     Abstract available

  13. GADDUCCI A, Giuliani D, Cosio S, Lissoni A, et al
    Clinical Outcome of Patients With Malignant Tumors Associated With Mature Cystic Teratomas of the Ovary: A Retrospective Multicenter Italian Study.
    Anticancer Res. 2019;39:2513-2517.
    PubMed     Abstract available

    April 2019
  14. OKI T, Sugimoto T, Ogawa M, Dabanaka K, et al
    Evaluation of Follow-up Examinations Using Ultrasonography for Patients With Thyroid Nodules Initially Diagnosed as Benign.
    Anticancer Res. 2019;39:2061-2067.
    PubMed     Abstract available

    March 2019
  15. SPARTALIS E, Athanasiadis DI, Chrysikos D, Spartalis M, et al
    Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
    Anticancer Res. 2019;39:1119-1127.
    PubMed     Abstract available

    February 2019
  16. LI MU, Gu S, Mao R, Ning Y, et al
    County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer.
    Anticancer Res. 2019;39:949-956.
    PubMed     Abstract available

    January 2019
  17. ZEMBSKA A, Jawiarczyk-Przybylowska A, Wojtczak B, Bolanowski M, et al
    MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma.
    Anticancer Res. 2019;39:33-40.
    PubMed     Abstract available

    December 2018
  18. DOMOSLAWSKI P, Pula B, Olbromski M, Wojtczak B, et al
    Expression of Metallothionein I/II and Ki-67 Antigen in Graves' Disease.
    Anticancer Res. 2018;38:6847-6853.
    PubMed     Abstract available

  19. FUSHIMI A, Takeyama H, Manome Y
    Effect of Heparin-Protamine Treatment on Thyroid Cancer Cell Lines.
    Anticancer Res. 2018;38:6759-6762.
    PubMed     Abstract available

  20. MASSIMINO M, Tirro E, Stella S, Frasca F, et al
    Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells.
    Anticancer Res. 2018;38:6653-6662.
    PubMed     Abstract available

    November 2018
  21. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.
    Anticancer Res. 2018;38:6339-6352.
    PubMed     Abstract available

  22. TURBAT-HERRERA EA, Kilpatrick MJ, Chen J, Meram AT, et al
    Cystathione beta-Synthase Is Increased in Thyroid Malignancies.
    Anticancer Res. 2018;38:6085-6090.
    PubMed     Abstract available

    September 2018
  23. OWEN C, Constantinidou A, Miah AB, Thway K, et al
    Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.
    Anticancer Res. 2018;38:5275-5282.
    PubMed     Abstract available

    June 2018
  24. KIM YJ, Hwang HJ, Kang JG, Kim CS, et al
    Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Anticancer Res. 2018;38:3515-3525.
    PubMed     Abstract available

  25. GADDUCCI A, Pistolesi S, Guerrieri ME, Cosio S, et al
    Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Anticancer Res. 2018;38:3669-3675.
    PubMed     Abstract available

    May 2018
  26. SHIH YL, Huang YH, Lin KH, Chu YD, et al
    Identification of Functional Thyroid Stimulating Hormone Receptor and TSHR Gene Mutations in Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:2793-2802.
    PubMed     Abstract available

    April 2018
  27. DZIGGEL L, Gebauer N, Bartscht T, Schild SE, et al
    Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Anticancer Res. 2018;38:2391-2394.
    PubMed     Abstract available

    March 2018
  28. NERVO A, Gallo M, Sama MT, Felicetti F, et al
    Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice.
    Anticancer Res. 2018;38:1643-1649.
    PubMed     Abstract available

    January 2018
  29. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Abstract available

    October 2017

  30. Thyroid Cancer and Nuclear Accidents. 1st Edition.
    Anticancer Res. 2017;37:5908.

  31. DO SI, Kim HS, Kim K, Lee H, et al
    Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.
    Anticancer Res. 2017;37:5399-5405.
    PubMed     Abstract available

    September 2017
  32. WOJTCZAK B, Pula B, Gomulkiewicz A, Olbromski M, et al
    Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
    Anticancer Res. 2017;37:5179-5185.
    PubMed     Abstract available

  33. AMPIL F, Ellika S, Nanda A, Vora M, et al
    Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up.
    Anticancer Res. 2017;37:5113-5115.
    PubMed     Abstract available

    April 2017
  34. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Abstract available

    March 2017
  35. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Abstract available

    January 2017

  36. Thyroid Cancer. A Comprehensive Guide to Clinical Management. Third Edition.
    Anticancer Res. 2017;37:361.

    October 2016
  37. DAMASKOS C, Valsami S, Spartalis E, Antoniou EA, et al
    Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
    Anticancer Res. 2016;36:5019-5024.
    PubMed     Abstract available

    September 2016
  38. KASMANN L, Bolm L, Janssen S, Rades D, et al
    Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer.
    Anticancer Res. 2016;36:4697-700.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.